Related Experiment Video
Updated: Dec 27, 2025

04:09
Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
Published on: September 20, 2024
700
[Treatment of Recurrent Thymoma]
Xianping Liu1, Xiao Li1, Jianfeng Li1
1Department of Thoracic Surgery, Peking University People's Hospital, Beijing 100044, China.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|February 27, 2020
Summary
Recurrent thymoma, a challenging cancer, lacks standard treatment. This review explores options like surgery, chemotherapy, and immunotherapy to guide future clinical decisions for thymoma patients.
Area of Science:
- Oncology
- Thoracic Surgery
- Medical Oncology
Background:
- Thymoma is a rare malignancy with a significant recurrence rate (10-30%) after initial treatment.
- Current treatment strategies for recurrent thymoma lack consensus, leading to varied clinical approaches.
Purpose of the Study:
- To review and synthesize existing literature on the management of recurrent thymoma.
- To summarize indications, efficacy, and prognostic factors for various treatment modalities.
Main Methods:
- Comprehensive literature search of studies on recurrent thymoma treatment.
- Analysis of treatment outcomes including reoperation, chemotherapy, radiotherapy, targeted therapy, and immunotherapy.
Main Results:
- Evidence suggests varying efficacy and prognoses for different treatment options in recurrent thymoma.
- Identifying optimal treatment criteria remains a challenge due to heterogeneity in patient populations and disease characteristics.
Conclusions:
- A standardized approach to recurrent thymoma treatment is needed.
- This review provides a reference for establishing treatment guidelines and improving patient outcomes for recurrent thymoma.
Related Concept Videos
Chronic Pharyngitis
9.9K
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
9.9K
Myasthenia Gravis: Overview and Treatment
2.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.6K
Tonsillitis II: Management
357
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
357
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Pneumothorax-II
767
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
767

